Market Expansion

Doha – September 22, 2026 -- OxiWear Inc. has signed an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) to bring its wearable physiological measurement technology into Qatar, marking the U.S. company's latest push into the Middle East.

OxiWear taps AMNM's local network to enter Qatar's healthcare technology market

Under the agreement, OxiWear and AMNM will jointly handle distribution, market development, and customer engagement for OxiWear's continuous physiological measurement products across Qatar. AMNM, a multi-specialty day-care surgery center based in Lusail and operated in affiliation with Chicago-based Northwestern Medicine, provides OxiWear with an established clinical network and regional expertise in outpatient care.

Burbank – – September 22, 2026 -- CJ 4DPLEX and Pathé Cinémas have signed a new agreement to install four SCREENX auditoriums across France, Belgium, and the Netherlands, with all locations set to open by the end of 2026.

Pathé adds two Belgian sites, one French and one Dutch location under the new deal

The rollout includes two SCREENX venues in Belgium, one in France, and one in the Netherlands, expanding the format's footprint in three of Europe's most active cinema markets. The agreement extends a partnership that began with the introduction of 4DX to European audiences and led to the launch of SCREENX at Pathé La Villette in Paris in 2018.

Dallas-Plano, Texas – September 22, 2026 -- Sportball is opening its first corporate-operated location in the United States in Dallas-Plano this fall, marking a shift from a two-decade-old franchise-only U.S. model to direct company operations. The Canadian youth sports company will also add a new franchise in Frisco-McKinney, expected to open in early 2027.

Las Vegas – September 22, 2026 -- TCSJOHNHUXLEY and entertainment figure Curtis "50 Cent" Jackson will unveil 50 Cent HeadcrackTM, a licensed live casino dice game adapting the century-old street game Cee-Lo, at G2E Las Vegas 2026. The game debuts at Booth #4439 inside The Venetian Expo from September 29 to October 1, 2026.

Live casino dice game debuts at G2E with a published pay table and licensed rules

50 Cent HeadcrackTM pits the Bank against the Shooter on every hand, with a Tie bet and multiple side wagers on the table: 5-5-6, HEADCRACKTM itself, Any Trips, 1-2-3 Natural Bust, a bundled Cover All wager, and a standalone Four or Better bet. The game retains the classic rules and vocabulary of Cee-Lo, also known as Four-Five-Six, a name derived from the Chinese term for the unbeatable 4-5-6 roll that has anchored the game for more than a hundred years.

Budapest – September 22, 2026 -- South Korean biopharmaceutical company PharmaResearch officially launched its REJURAN portfolio of polynucleotide (PN)-based skin boosters in Hungary, marking its latest expansion move in Europe's aesthetic medicine market.

Symposium at Budapest museum draws 100 aesthetic medicine professionals

The launch event was held on September 14 at the Museum of Fine Arts, Budapest, marking REJURAN's first collaboration with the institution. Approximately 100 dermatologists, plastic surgeons and other aesthetic medicine specialists attended the symposium, which featured seven speakers from Korea, the Czech Republic, Slovakia and Hungary, including Korean key opinion leaders Dr. Hyun Jun Park and Dr. Kyu Ho Lee.

Los Angeles – September 22, 2026 -- Creator TV, the streaming network owned by Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF), reported its audience grew 4.8 times year-to-date through August 2026, hitting a record 305,000 unique viewers that month.

Audience growth accelerates as average monthly viewership climbs 138% year-over-year

Sabio's App Science analytics platform found Creator TV viewers are 2.5 times more likely to stream sports content than average audiences, a data point the company says explains the crossover between creator-economy fans and sports viewership.

Taipei – September 21, 2026 -- EVA Air secured three No. 1 titles at the 2026 SKYTRAX World Airline Awards -- World's Best Premium Economy Class, World's Best Premium Economy Class Airline Amenities, and World's Most Family Friendly Airline -- while logging 18 Top Ten rankings overall and retaining its SKYTRAX 5-Star Airline rating for an 11th consecutive year.

Carrier sweeps premium economy categories as segment growth accelerates

SKYTRAX CEO Edward Plaisted noted that EVA Air introduced Premium Economy in 1992, positioning the Taiwanese carrier as an early mover in what he described as aviation's fastest-growing cabin category. The airline's win in the family-friendly category recognizes measures aimed at easing travel for passengers with children, according to SKYTRAX.

CHARLESTON, S.C. – – September 21, 2026 -- VIO Med Spa has signed a three-unit development agreement to enter South Carolina for the first time, with the first Charleston-area location targeted to open in 2027. Site selection is currently underway.

Former CVS Health Executive Leads Local Development

Ted Loya, who spent more than 23 years at CVS Health in its pharmacy benefits business working with national employers, will spearhead the brand's build-out across the Charleston area. New to franchising and medical aesthetics, Loya cited VIO's established infrastructure, financial backing, and existing East Coast footprint in North Carolina and Georgia as deciding factors in bringing the brand to South Carolina.

Deal Extends Brand's East Coast Footprint

Ryan Rao, Chief Development Officer at VIO Med Spa, said the Charleston entry strengthens the company's presence in the Southeast and supports further expansion along the East Coast.

New York – September 21, 2026 -- Infrastructure Capital Advisors has expanded its SPYC exchange-traded fund into Europe, securing listings on the London Stock Exchange, Deutsche Börse Xetra and Borsa Italiana while registering the product across 11 European markets.

SPYC pairs S&P 500 equities with a covered-call overlay to generate monthly income

The fund combines actively selected S&P 500 stocks with a flexible covered-call options strategy, aiming to produce monthly income distributions while preserving upside potential for capital growth. Infrastructure Capital designed the structure to monetize elevated volatility across S&P 500-listed companies through active options management.

Singapore – September 20, 2026 -- Specialised Therapeutics (ST) has expanded its partnership with Incyte Biosciences International to commercialise, distribute, and register ruxolitinib cream, marketed as Opzelura, in Australia.

ST gains rights to market Opzelura for vitiligo and atopic dermatitis in Australia

Under the expanded agreement, Incyte will continue to develop and manufacture ruxolitinib cream, a topical Janus kinase (JAK) inhibitor, while ST takes on regulatory submissions, medical affairs, marketing, and distribution across the Australian market. The drug is approved in the U.S. and European Union for treating non-segmental vitiligo and mild-to-moderate atopic dermatitis in patients who do not respond adequately to standard topical therapies.